🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to the newest members of the European Society of Thoracic Surgeons ESTS ESTS Board of Directors - Drs. Cecilia Pompili Cecilia Pompili MD PhD FACS, Clemens Aigner, and Raul Embun Raul Embun and new President, Dr. Pierre-Emmanuel Falcoz!

📅 Did you know there's only one week left to submit your CARE Award nomination? ⭐ If you're looking for tips, don't miss this interview with last year's winner & her nominator, who share key advice for nominating an oncology nurse or APP! ➡️ Watch: buff.ly/xeX50xo

This is what happens when you walk into the #ASCO25 Patient Advocacy lounge with a few The White Ribbon Project™ ribbons. Thanks Heidi Nafman-Onda & Jill Feldman for helping me bring a big bunch of mini ribbons back to the UK 🇬🇧 Smaller ribbons; just as powerful. #LCSM

📰 Catching up on news from #ASCO25? 🫁 Don't miss our #lcsm-focused coverage! ➡️ Find it here: buff.ly/dqYkpql #ASCO2025 #LungCancer #NSCLC #SCLC

📆 Only a few days remaining to nominate a nurse or APP for the 2025 CARE Award! 🌟 In this clip, hear from 2024 CARE Award Winner Jennifer Margolis, BSN, RN, OCN, who shares why it's critical to nominate a colleague . ➡️ Submit your nomination here: buff.ly/3LeddlD

🫁 What's the latest on REZILIENT1? ⭐ Don't miss this insightful interview with Helena Yu, MD, of Memorial Sloan Kettering Cancer Center, who unpacks key data from her #ASCO25 oral abstract presentation on the study and discusses next steps. ➡️ Learn more: buff.ly/8eHs24b #NSCLC #lcsm

📰 ICYMI: The phase 3 IMforte trial has met its primary endpoints of OS and PFS, according to an #ASCO25 presentation by Luis Paz-Ares. ➡️ Learn more: buff.ly/R7gQK7S #SCLC #ASCO2025 #lcsm

📰 BREAKING: The FDA has granted approval to taletrectinib for the treatment of locally advanced or metastatic ROS1-positive NSCLC. ➡️ Learn more: buff.ly/AyKO0Aq #lcsm #NSCLC #ROS1 #lcsm

🫁 Catching up on all the news from #ASCO25? 📰 Don't miss our #lcsm-focused coverage! ➡️ Find lung cancer news and updates from #ASCO2025 here: buff.ly/dqYkpql #NSCLC #lcsm #SCLC #LungCancer

Great to be part of the #LungSHOT masterclass on lung cancer screening at Queen's University Belfast 🎓 today #LCSM #ScreeningSavesLives #IrishLungCancerCommunity Trinity St James's Cancer Institute *reposted with the correct Queen's now ethna ☺️

💡 Did you know there's still time to nominate an oncology nurse for the CARE Award? ⭐ Hear from last year's winner Jennifer Margolis, BSN, RN, of Rush University System for Health, on the importance of recognizing nurses who make a difference! 📋 Nominate a nurse here: buff.ly/fQK7ghH

🤩 ICYMI: Coral Olazagasti, MD and Maria Antonia Vélez joined us for an amazing interview at #ASCO25 to reflect on research, mentorship, and collaboration at the annual meeting! ➡️ Watch: buff.ly/Kgd7TZO #lcsm #ASCO2025 #lungcancer ASCO

📰 Catching up on news from #ASCO25 this weekend? 🫁 Don't miss our #lcsm-focused coverage! ➡️ Find it here: buff.ly/dqYkpql #ASCO2025 #LungCancer #NSCLC #SCLC

☀️ LAST CALL: Nominations for the 2025 CARE Award close tonight at 11:59 PT tonight! 🙏 Thank you to everyone who already nominated their incredible oncology nursing colleagues, mentors, and friends! 📋 Nominate a nurse here before time runs out: buff.ly/fQK7ghH

📰 ICYMI: The phase 3 IMforte trial has met its primary endpoints of OS and PFS, according to an #ASCO25 presentation by Luis Paz-Ares. ➡️ Learn more: buff.ly/R7gQK7S #SCLC #ASCO2025 #lcsm

🚨 ICYMI: The U.S. FDA granted accelerated approval to telisotuzumab vedotin-tllv to treat certain adults with locally advanced or metastatic non-squamous NSCLC who have received a prior systemic therapy! 📖 Read more: buff.ly/ypg9iYd #NSCLC #lcsm #FDA #lungcancer

Great to speak on "AI in Oncology" at the Japanese Lung Cancer Society's Preceptorship Program 2025 特定非営利活動法人 日本肺癌学会 ! Meaningful discussions on AI's potential in cancer care & research. Excited to explore more possibilities for AI in oncology. #LCSM

Huge thanks to Stephanie Stephanie Saw for her inspiring and informative talk with young lung oncologists in Japan! Her dedication and mentorship are truly impressive to me. This global collaboration and friendship are what I love about #LCSM

1/3 🫁 #Afatinib vs Chemotherapy with #Uncommon #EGFR Mutations: ACHILLES/TORG1834 ⭐️ Final OS analysis #ASCO25 Abstract #8623 #egfr #LCSM #uncommon #compound #afatinib

🫁 Adagrasib plus pembrolizumab showed “promising clinical efficacy” in the KRYSTAL-7 trial, according to an #ASCO25 presentation by Pasi Jänne, MD, PhD, FASCO, of Dana-Farber's Lowe Center for Thoracic Oncology, Dana-Farber. ➡️ Learn more: buff.ly/2jjb9oc #lcsm #NSCLC #KRAS #ASCO2025